The people of ASI possess the two key requisites for success. The stellar research capabilities and knowledge required to create exciting new products -- with core competencies in optical physics, software development and molecular biology.

And the international commercial experience needed to bring them to market -- with a presence through direct teams plus well-known distributors in the United States, Israel, Europe and the Far East.

Our capabilities were recognized in 1997 when we were awarded the European Information Technology Prize for successful commercialization of our revolutionary cytogenetics technology. And we've been expanding our scope ever since.

	H. Laurence Shaw, M.D., Chief Executive Officer, Director Dr. Shaw joined ASI in March 1999. Prior to that he was CEO and President of Pacific Pharmaceuticals, Inc. and Chairman of its board. From 1995-1997, he served as Corporate Vice President of Research and Development at C.R. Bard, Inc. He founded Atlantic Pharmaceuticals, a public company, and was its CEO and President from 1993-1995. At Abbott Laboratories, from 1984-1993, he served ultimately as Vice President of Medical and Regulatory Affairs and Advanced Research for the Hospital Products Division.
	Yacov Malinovich, Ph. D., Vice President Research & Development Dr. Malinovich joined ASI in March 2002. Prior to that he was Director of CMOS Operations at 3DV Systems, Ltd, which develops three-dimension video cameras. With a background in both large technology companies and cutting edge start-ups he brings ASI extensive managerial experience in developing and bringing to market medical imaging systems. His scientific expertise includes a broad background in imaging systems, imaging sensors, lasers and electro-optics.
	Nir Katzir, M.Sc., Chief Scientist Since joining ASI in 1993, Mr. Katzir has played a major role in developing the algorithms for our technology, and developing its applications. Along with managing key projects at ASI, he is coauthor of many of our patents and papers.
	Limor Shiposh, Controller & Commercial Director Mrs. Shiposh joined ASI in May 1999. From 1990-1999 she was Controller & CFO in Rada Electronics Industries Ltd., a publicly traded company on NASDAQ, with subsidiaries in USA, Europe & the Far East. From 1988-1990 she was Deputy Internal Auditor for the Israeli Ministry of Defense Procurement Office in New York. She has experience in contract negotiations in government funding and purchasing, business negotiations and contracts.
	Irit Bar Am, Ph.D., Kits Development Manager Dr. Irit Bar-Am, Ph.D. is responsible for the development and production of our molecular probe kits. She also plays a key role in developing new applications in cytogenetics as well as conducting clinical utility studies. With over thirty publications, she is considered one of Israel's experts in FISH (fluorescent in situ hybridization), a technique which has revolutionized both research and clinical analysis in cytogenetics.
	Michael Koehler, Ph.D., Technical and Scientific Manager, Germany Dr. Koehler heads ASI's European office in Mannheim, Germany, which is responsible for sales in Germany, the Netherlands, Austria, and Switzerland, as well as for technical support of ASI customers and distributors throughout Europe. He is first-author and co-author of numerous scientific articles published in peer-reviewed scientific journals.

BOARD OF DIRECTORS:


Ed Mlavsky, Ph.D. -- Chairman
Dr. Mlavsky is Chairman of Gemini Israel Venture Funds and the previous Executive Director of the BIRD (Israel -- U.S. Binational Industrial Research and Development) Foundation. He is also a co-founder of Tyco International, Inc.

Dario Cabib, Ph.D.
Dr. Cabib is co-founder of Applied Spectral Imaging Ltd. He is also co-founder of CI Systems Ltd, PetroMetriX Ltd and BeamWorks Ltd.

Tamar Ciehanover
Ms. Ciehanover is a Vice President at Challenge I and II Funds and a member of the Funds' Management Committee.

Bernard Daugeras, Ph.D.
Dr. Daugeras is the founder of Auriga Partners.

Rolf Haegler
Mr. Haegler is managing director of Transatlantic Atlantic Technology (TAT). He is an acknowledged specialist in medical technology investments.

Graham I. Jackson, Ph.D.
Dr. Jackson is an experienced international lecturer and consultant in Marketing. He worked in the Marketing Departments of IBM (UK) and Procter & Gamble (UK) and was an Action Learning consultant in the Scandinavian Institutes of Administrative Research.

Noam Karstaedt
Mr. Karstaedt is the president of Denali Ventures, LLC. He has been an active member of the Israeli venture capital community for more than 10 years, and in 1992 helped pioneer Israel's first life science VC fund, MedMax Ventures.

Joseph Rabi
Mr. Rabi is a venture partner of the Yozma fund. In the past several years, Mr. Rabi has played an active role in strengthening Yozma's foothold in the Asian and European markets.

H. Laurence Shaw, MD
Dr. Shaw is Chief Executive Officer of Applied Spectral Imaging